Should CAC Score Be Used to Guide Statin Therapy?
the MPR take:
A study published in the journal Circulation: Cardiovascular Quality and Outcomes, questions whether coronary artery calcium (CAC) score should be used to guide therapy with statins. Measuring CAC is useful in predicting future coronary heart disease; however, it comes with risk, namely exposure to low-dose radiation. After analyzing the cost/benefit of CAC measuring in different scenarios, researchers concluded that using this technique would only benefit patients with intermediate risk and only if statins affected quality of life or were too costly. For other patients, a treat-all approach was preferable to CAC screening, when other factors such as drug cost and quality of life were favorable.
READ FULL ARTICLE From circoutcomes.ahajournals.org